Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Filomena Caiaffa

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Postepy Dermatologii I Alergologii|March 13, 2019
Immunological characterization of onion (<i>Allium cepa</i>) allergyMarcello Albanesi, Carlo Pasculli, Lucia Giliberti, et al.
Clinical and Molecular Allergy : CMA|November 3, 2018
Rapid desensitization for brentuximab vedotin (Adceteris<sup>®</sup>) allergy: a case reportAttilio Di Girolamo, Marcello Albanesi, Alessandro Sinisi, et al.
Clinical and Molecular Allergy : CMA|December 9, 2020
Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro managementStefania Magistà, Marcello Albanesi, Nada Chaoul, et al.
International Archives of Allergy and Immunology|March 29, 2019
Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic EffectsNada Chaoul, Marcello Albanesi, Lucia Giliberti, et al.
Respiratory Medicine|November 29, 2019
Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective studyDanilo Di Bona, Stefania Magistà, Lucia Masciopinto, et al.
Pulmonary Pharmacology & Therapeutics|October 5, 2014
Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in ItalyFederica Novelli, Manuela Latorre, Letizia Vergura, et al.
Respiratory Medicine|December 6, 2017
Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year studyDanilo Di Bona, Irene Fiorino, Marialuisa Taurino, et al.
Clinical and Molecular Allergy : CMA|January 30, 2018
A 13-year real-life study on efficacy, safety and biological effects of <i>Vespula</i> venom immunotherapyMarcello Albanesi, Andrea Nico, Alessandro Sinisi, et al.
Frontiers in Immunology|February 8, 2024
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remissionGiovanna Elisiana Carpagnano, Andrea Portacci, Santi Nolasco, et al.
Journal of Clinical Medicine|July 14, 2023
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life ExperienceGiulia Scioscia, Pasquale Tondo, Santi Nolasco, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Postepy Dermatologii I Alergologii|March 13, 2019
Immunological characterization of onion (<i>Allium cepa</i>) allergyMarcello Albanesi, Carlo Pasculli, Lucia Giliberti, et al.
Clinical and Molecular Allergy : CMA|November 3, 2018
Rapid desensitization for brentuximab vedotin (Adceteris<sup>®</sup>) allergy: a case reportAttilio Di Girolamo, Marcello Albanesi, Alessandro Sinisi, et al.
Clinical and Molecular Allergy : CMA|December 9, 2020
Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro managementStefania Magistà, Marcello Albanesi, Nada Chaoul, et al.
International Archives of Allergy and Immunology|March 29, 2019
Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic EffectsNada Chaoul, Marcello Albanesi, Lucia Giliberti, et al.
Respiratory Medicine|November 29, 2019
Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective studyDanilo Di Bona, Stefania Magistà, Lucia Masciopinto, et al.
Pulmonary Pharmacology & Therapeutics|October 5, 2014
Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in ItalyFederica Novelli, Manuela Latorre, Letizia Vergura, et al.
Respiratory Medicine|December 6, 2017
Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year studyDanilo Di Bona, Irene Fiorino, Marialuisa Taurino, et al.
Clinical and Molecular Allergy : CMA|January 30, 2018
A 13-year real-life study on efficacy, safety and biological effects of <i>Vespula</i> venom immunotherapyMarcello Albanesi, Andrea Nico, Alessandro Sinisi, et al.
Frontiers in Immunology|February 8, 2024
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remissionGiovanna Elisiana Carpagnano, Andrea Portacci, Santi Nolasco, et al.
Journal of Clinical Medicine|July 14, 2023
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life ExperienceGiulia Scioscia, Pasquale Tondo, Santi Nolasco, et al.
Pageof 5